GlaxoSmithKline Plc and the U.S. Patent and Trademark Office await
a decision by the U.S. Court of Appeals for the Federal Circuit
(CAFC) regarding rules governing patent applications and claims.
provides in-depth news coverage of intellectual property lawsuits involving public companies with assets of USD $1 billion or more. Coverage focuses on the infringement of intellectual property rights (including patents, copyrights, trademarks, trade dress, trade secrets, and royalties) and corporate indemnification of intellectual property violations.